The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 13, 2015
Filed:
Oct. 09, 2009
Matteo Iannacone, Boston, MA (US);
Ulrich Von Andrian, Chestnut Hill, MA (US);
Omid C. Farokhzad, Chestnut Hill, MA (US);
Frank Alexis, Greenville, SC (US);
Pamela Basto, Somerville, MA (US);
Jinjun Shi, Boston, MA (US);
Elliott Ashley Moseman, Jamaica Plain, MA (US);
Robert S. Langer, Newton, MA (US);
Elena Tonti, Riccione, IT;
Matteo Iannacone, Boston, MA (US);
Ulrich von Andrian, Chestnut Hill, MA (US);
Omid C. Farokhzad, Chestnut Hill, MA (US);
Frank Alexis, Greenville, SC (US);
Pamela Basto, Somerville, MA (US);
Jinjun Shi, Boston, MA (US);
Elliott Ashley Moseman, Jamaica Plain, MA (US);
Robert S. Langer, Newton, MA (US);
Elena Tonti, Riccione, IT;
Massachusetts Institute of Technology, Cambridge, MA (US);
President and Fellows of Harvard College, Cambridge, MA (US);
The Brigham and Women's Hospital, Inc., Boston, MA (US);
Abstract
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface having a plurality of nicotine moieties. The invention provides pharmaceutical compositions comprising nanocarriers. The present invention provides methods of designing, manufacturing, and using nanocarriers and pharmaceutical compositions thereof. For example, the present invention describes nanocarriers capable of eliciting an immune response and the production of anti-nicotine antibodies.